








































neurons.	 Recent	 neuroimaging	 studies	 suggest	 that	 resting	 hippocampal	 perfusion	 is	 increased	 in	
subjects	at	ultra-high	risk	(UHR)	for	psychosis,	but	how	this	may	be	related	to	GABA	concentrations	is	
unknown.	The	present	study	used	a	multimodal	neuroimaging	approach	to	address	this	issue	in	UHR	





















Lewis	 et	 al,	 2005).	 More	 specifically,	 schizophrenia	 has	 been	 linked	 to	 a	 defect	 in	 glutamate	
decarboxylase	 (GAD67)	mRNA	 in	parvalbumin-expressing	 (PV+)	 interneurons	within	a	corticolimbic	
circuit	involving	the	prefrontal	cortex	and	the	hippocampus	(Akbarian	and	Huang,	2006;	Benes,	2010).	
Recent	work	on	a	neurodevelopmental	animal	model	of	psychosis	(Moore	et	al,	2006)	indicates	that	
medial	 prefrontal	 cortex	 (MPFC)	 dysfunction	 leads	 to	 increased	 stress-induced	 functional	 loss	 of	
hippocampal	 PV+	 interneurons	 (Gomes	 and	 Grace,	 2017),	 which	 is	 associated	 with	 hippocampal	
hyperactivity	 through	 disinhibition	 of	 glutamatergic	 pyramidal	 cells	 (Grace,	 2010).	 Increased	
glutamatergic	 output	 from	 the	 ventral	 hippocampus	 is	 hypothesized	 to	 then	 lead	 to	 elevated	
subcortical	 dopamine	 function,	 resulting	 in	 some	 of	 the	 behavioral	 abnormalities	 associated	with	
schizophrenia	 (Grace,	 2016).	 Furthermore,	 independent	 research	 using	 other	 preclinical	 models	



























resting	perfusion	is	 increased	in	the	hippocampus	in	 individuals	at	UHR	of	psychosis	(Allen	et	al,	 In	
press;	 Allen	 et	 al,	 2016),	 and	 similar	 findings	 in	 UHR	 have	 been	 reported	 using	 other	 magnetic	
resonance	 imaging	 methods	 involving	 intravenous	 injections	 of	 the	 contrast	 agent	 gadolinium	 to	
measure	basal	cerebral	blood	volume	(Schobel	et	al,	2009).	In	patients	with	schizophrenia	compared	
to	healthy	controls,	hyperperfusion	in	the	hippocampus	has	been	documented	(Friston	et	al,	1992;	
Heckers	and	Konradi,	2015;	 Liddle	 et	al,	 1992),	 as	well	 as	 in	other	brain	 regions	 such	as	 the	basal	
ganglia	and	middle	temporal	lobes	(Pinkham	et	al,	2011),	cerebellum,	brainstem	and	thalamus	(Scheef	
et	al,	2010),	although	the	latter	two	studies	did	not	report	significant	effects	in	hippocampus.	The	aim	





(Egerton	 et	 al,	 2017a),	 (ii)	 preclinical	models	 indicate	 that	MPFC	deficits	 dysregulate	 hippocampal	

















the	 Centre	 for	 Neuroimaging	 Sciences,	 Institute	 of	 Psychiatry,	 Psychology	 &	 Neuroscience	 (King’s	
College	 London),	 in	 a	 single	 session.	 All	 clinical	 assessments	were	 conducted	 on	 the	 same	 day	 of	
scanning	at	King’s	College	London	by	trained	researchers.	The	different	sites	were:	OASIS	(Outreach	
and	Support	in	South	London)	(Fusar-Poli	et	al,	2013),	part	of	the	SLaM	NHS	Trust	(n	=	22);	CAMEO,	
part	 of	 the	Cambridge	 and	Peterborough	NHS	 Trust	 (n	 =	 11);	 the	West	 London	 Early	 Intervention	
Service	 (n	 =	 2);	 and	 the	 Coventry	 and	Warwick	 NHS	 Trust	 (n	 =	 1).	 Inclusion	 criteria	 involved	 the	
presence	 of	 one	 (or	more)	 of	 the	 following:	 (1)	 attenuated	 psychotic	 symptoms	 (APS),	 (2)	 a	 brief	




1994).	 UHR	 signs	 and	 symptoms	 for	 inclusion	 criteria	 were	 assessed	 with	 the	 Comprehensive	







diagnosis	 of	 psychotic	 disorders,	 past/present/familiar	 history	 of	 neurological	 illness,	 substance	
abuse/dependence	 as	 defined	 using	 DSM-5	 criteria	 (American	 Psychiatric	 Association,	 1994),	 or	





CAARMS	 (Yung	 et	 al,	 2005);	 anxiety	 and	 depression	 symptoms	 using	 the	 Hamilton	 Anxiety	 and	
Depression	Scales	(HAM-A	/	HAM-D)	(Hamilton,	1959);	and	social	and	occupational	functioning	using	
the	GAF	(American	Psychiatric	Association,	1994).	Medication	history	and	use	of	alcohol,	tobacco	and	
illicit	 drugs	 was	 assessed	 using	 a	 semi-structured	 interview	 adapted	 from	 the	 Early	 Psychosis	
Prevention	 and	 Intervention	 Centre	 (EPPIC)	 Drug	 and	 Alcohol	 Assessment	 Schedule	
(http://www.eppic.org.au).	 At	 follow-up,	 clinical	 outcomes	 were	 determined	 using	 the	 CAARMS	
Psychosis	Threshold	criteria	(Yung	et	al,	2005)	and	confirmed	with	the	Structured	Clinical	Interview	
for	Diagnosis	(American	Psychiatric	Association,	1994)	as	administered	by	an	experienced	psychiatrist.	
Seven	 of	 the	 UHR	 subjects	 (19%)	 developed	 a	 psychotic	 disorder	 (the	 psychotic	 transition	 group)	

















To	 maximize	 sensitivity	 to	 blood	 perfusion,	 background	 suppression	 was	 achieved	 by	 selective	
saturation	of	the	image	slab	at	4.3s	before	acquisition,	selective	inversion	3s	before	acquisition	and	
non-selective	inversions	at	1.5s,	764ms,	334ms	and	84ms	before	imaging.	A	proton-density	calibration	







CBF	 maps	 were	 preprocessed	 using	 FMRIB	 Software	 Library	 (FSL)	 software	 applications	
(http://www.fmrib.ox.a.c.uk/fsl)	 and	 Statistical	 Parametric	 Mapping	 (SPM8;	
http://www.fil.ion.ucl.ac.uk/spm/).	A	multi-step	approach	was	performed	including	the	pCASL,	the	T2	
and	 the	 SPGR	 scans:	 (1)	 elimination	 of	 extra-cerebral	 signal	 from	 the	 T2	 scan	 using	 the	 “Brain	























Spectra	 were	 analyzed	 using	 LCModel	 version	 6.3-1L	 (http://s-
provencher.com/pages/lcmodel.shtml)	with	the	basis	set	provided	by	its	author	(Provencher,	1993,	
2016).	Water-scaled	 GABA+	 values	 were	 corrected	 for	 the	 voxel	 tissue	 composition	 by	 using	 the	
formula:	Metabolite	 Corrected	 =	Metabolite	 Concentration	 *	 [proportion	white	matter	 +	 (1.283	 *	
proportion	 gray	 matter)	 +	 (1.55	 *	 proportion	 corticospinal	 fluid)]	 /	 (proportion	 white	 matter	 +	









analysis	 (Mouchlianitis	et	al,	2016;	Provencher,	2016).	Data	 from	all	36	participants	 in	 the	present	
study	met	these	criteria.	The	GABA	1H-MRS	data	from	the	male	participants	in	this	sample	(n	=	21)	
overlaps	with	the	dataset	recently	reported	as	part	of	a	case-control	study	in	males	(Modinos	et	al,	







group	 (psychotic	 transition,	non-transition)	on	demographic	and	clinical	variables	was	 tested	using	








Between-group	 differences	 in	 rCBF	 were	 examined	 with	 an	 independent	 samples	 t-test	 using	
Statistical	Parametric	Mapping	Version	8	(http://www.fil.ion.ucl.ac.uk/spm/software/spm8).	Age	and	
gender	as	covariates	of	no	interests.	Hippocampal	ROIs	were	specified	a	priori	using	the	coordinates	















group	differences	 in	 rCBF-GABA+	associations	 in	UHR	 subjects	who	 later	 transitioned	 to	 psychosis	
(UHR-T)	and	those	who	did	not	(UHR-NT).	Hippocampal	ROIs	were	specified	a	priori	using	the	same	
































































































The	 main	 finding	 of	 the	 present	 study	 was	 that	 MPFC	 GABA+	 levels	 were	 related	 to	 resting	









Preclinical	 models	 propose	 that	 cortical	 inhibition	 deficits	 lead	 to	 hippocampal	
hyperexcitability	 in	 psychosis,	 and	 that	 resulting	 increased	 glutamatergic	 outputs	 from	 the	
hippocampus	 to	 the	 striatum	 dysregulate	 subcortical	 dopaminergic	 function	 (Lisman	 et	 al,	 2008).	























individuals	 may	 differ	 depending	 on	 the	 cortical	 region	 involved:	 a	 positive	 correlation	 has	 been	
reported	 for	 hippocampal	 activation	 (Allen	 et	 al,	 2012),	 but	 a	 negative	 correlation	 for	 prefrontal	
activation	(Fusar-Poli	et	al,	2010).	An	additional	consideration	is	that	in	preclinical	and	post-mortem	
studies	 the	 GABAergic	 abnormality	 appears	 to	 be	 specific	 to	 PV+	 neurons	 (Marin,	 2012),	 which	
account	for	~40%	of	the	cortical	GABAergic	interneuron	population.	In	contrast,	a	limitation	of	1H-MRS	
is	that	it	quantifies	total	tissue	concentrations	as	opposed	to	those	from	a	particular	GABA	cell	type,	
and	 increases	 could	 thus	 reflect	 changes	 in	 other	 classes	 of	 GABA	 interneuron.	 For	 example,	
compensatory	mechanisms	for	a	PV+	deficit	and/or	hippocampal	overdrive	might	involve	increased	
GABA	 levels	 in	PV-	 interneurons	 (Isaacson	and	Scanziani,	2011).	An	alternative	explanation	 for	 the	
observed	positive	correlation	between	MPFC	GABA+	levels	and	hippocampal	resting	perfusion	is	that	
intrinsic	hippocampal	GABAergic	dysfunction	may	result	in	hippocampal	hyperperfusion	in	psychosis	
(Heckers	 et	 al,	 2015)	 and	hence	GABAergic	 increases	 in	MPFC	 (de	 la	 Fuente-Sandoval	 et	 al,	 2016;	
Kegeles	et	al,	2012)	may	be	compensatory	in	nature.	Noteworthy,	the	measurement	of	hippocampal	
GABA	 function	 using	 1H-MRS	 is	 technically	 challenging	 and	 only	 one	 such	 study	 to	 date	 has	 been	
















reduced	 functional	 activation	 of	 ventrolateral	 PFC	 regions	 is	 a	 robust	 finding,	 along	 with	
hyperresponsivity	of	 limbic,	emotion-generation	regions	(Etkin	and	Wager,	2007).	Although	we	did	
not	have	a	specific	hypothesis	about	this	brain	area,	the	direction	of	the	association	with	GABA+	levels	
(negative)	 aligns	 with	 what	 would	 be	 hypothesized	 from	 preclinical	 and	 post-mortem	 findings.	






	 In	 terms	of	 limitations,	 the	present	 study	was	part	of	 a	 larger	multimodal	 imaging	project	
investigating	 the	 neurobiology	 of	 psychosis	 onset	 in	 UHR	 individuals,	 following	 an	 asymmetric	
prospective	design.	Both	rCBF	and	1H-MRS	data	could	not	be	collected	for	the	relatively	small	number	
of	healthy	controls	included	in	the	larger	project,	which	precluded	the	inclusion	of	a	comparison	group	
in	 this	 circuit-based	 UHR	 study.	 Furthermore,	 the	 size	 of	 the	 UHR	 sample	 limited	 the	 number	 of	
subjects	transitioning	to	psychosis	by	the	follow-up	point;	the	longitudinal	results	between	UHR-T	and	
UHR-NT	must	thus	be	interpreted	with	caution.	Future	longitudinal	studies	in	larger	UHR	samples	are	
warranted	 to	 clarify	 the	 prediction	 value	 of	 GABA-perfusion	 interactions	 for	 psychosis	 onset,	
confirm/refute	the	nature	of	our	positive	findings,	and	elucidate	whether	these	are	transdiagnostic	or	
rather	specific	to	different	types	of	psychotic	disorders.	There	was	a	trend	towards	higher	levels	of	
anxiety	 in	 the	 subgroup	 that	 transitioned	 to	 psychosis,	 but	 no	 significant	 association	 was	 found	
between	anxiety	scores	and	levels	of	GABA+,	and	the	GABA-hippocampal	rCBF	associations	and	group	
interactions	remained	significant	when	HAM-A	scores	were	included	as	covariate	of	no	interest	in	the	























































































































































































































































































































































	 Mean	(SD)	 Mean	(SD)	 Mean	(SD)	 Statistic	 p	
Age	(years)	 21.8	(2.9)	 21.7	(2.9)	 22.1	(3.0)	 t	=	.342	 .734	
Gender	(male	/	female)	 21	/	15	 17	/	12	 4	/	3	  c2	=	.005	 .943	
Estimated	IQ	 107.6	(11.6)	 107.8	(12.3)	 106.2	(7.3)	 t	=	-.276	 .784	
CAARMS	Positive	 11.9	(4.2)	 11.8	(4.1)	 12.6	(3.3)	 t	=.443	 .661	
CAARMS	Negative	 6.9	(4.42)	 6.8	(4.2)	 7.1	(5.7)	 t	=.173	 .864	
GAF	 58.3	(11.6)	 58.5	(11.3)	 57.9	(13.5)	 t	=	-.121	 .905	
HAM-A	 21.0	(11.7)	 18.6	(11.0)	 28.4	(11.4)	 t	=	2.046	 .051	
HAM-D	 19.2	(11.3)	 17.4	(11.9)	 24.6	(7.6)	 t	=	1.485	 .149	
Tobacco	(cigarettes/day)	 5.4	(8.2)	 6.4	(8.8)	 1.7	(3.3)	 t	=	-1.362	 .182	
Alcohol	(units/day)	 2.3	(4.6)	 2.7	(5.1)	 1.0	(0.6)	 t	=	-.854	 .399	
Cannabis	(median	[range])	 0	(0	–	4)	 0	(0	–	4)	 1	(0	–	4)	  c2	=	1.667	 .797	
Antipsychotic	medication	 0	 -	 -	 -	 -	
Benzodiazepines	 0	 -	 -	 -	 -	
Antidepressant	 medication	
(y/n)	
11/25	 9/20	 2/5	  c2	=	.016	 .899	
	


















	 Mean	(SD)	 Mean	(SD)	 Mean	(SD)	 Statistic	 p	
SNR	 21.9	(3.5)	 21.8	(3.2)	 22.7	(4.7)	 .650	 .520	
Line	width	 6.8	(2.9)	 7.0	(3.1)	 6.2	(1.7)	 -.692	 .494	
Voxel	CSF	 0.1	(0.1)	 0.1	(0.0)	 0.2	(0.1)	 .539	 .593	
Voxel	GM	 0.5	(0.4)	 0.5	(0.0)	 0.5	(0.0)	 -.497	 .622	
Voxel	WM	 0.3	(0.1)	 0.3	(0.0)	 0.3	(0.1)	 -.059	 .953	
GABA+	 3.9	(0.7)	 3.8	(0.6)	 4.2	(0.9)	 1.245	 .222	




































Figure	 3.	 Plots	 depicting	 the	 group	 by	 GABA+	 by	 rCBF	 interaction	 in	 left	 hippocampus	 from	 ROI	
analysis.	 Regression	 slopes	 were	 significantly	 different	 between	 UHR	 subjects	 with	 psychotic	
transition	(UHR-T)	and	UHR	subjects	without	transition	(UHR-NT).	rCBF	values	are	expressed	as	ratio	
over	global	rCBF.	Significant	effects	at	p	<	0.05	FWE.	
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rCBF	in	UHR	Individuals:	Relationship	to	Clinical	Outcome	
	
Figure	S1.	Section	overlay	and	plot	depicting	rCBF	differences	between	the	UHR-NT	and	UHR-T	groups	
at	the	whole-brain	level.	rCBF	values	are	expressed	as	ratio	over	global	rCBF.	Significant	effects	at	p	<	
0.05	FWE,	shown	at	p	<	.005	uncorrected	for	display	purposes.	
	
	
	
